Delivery Order SPE2DB20D6037-SPE2DB24FTWT4
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of epinephrine auto-injectors. The $4,154 contract has a performance period through July 31, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,026.48 firm fixed-price delivery order is for the provision of epinephrine auto-injectors, with a completion date of September 17, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), under the Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of various pharmaceutical products, including epinephrine auto-injectors, to support the medical supply needs of military health facilities worldwide. The contract has a ceiling value of $1,020.00 and an ultimate completion date of August 5, 2024....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of epinephrine auto-injectors to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is a firm fixed-price delivery order with a ceiling value of $3,400.00 and a period of performance through September 13, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of epinephrine auto-injectors to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $2,040.00 firm fixed-price delivery order has a completion date of September 11, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,189.60 firm fixed-price delivery order is for the supply of epinephrine auto-injectors and has an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of epinephrine auto-injectors, with a ceiling value of $1,040.58 and a completion date of June 9, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
The U.S. government awarded a $5,317.12 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of epinephrine auto-injectors. The contract has a completion date of May 30, 2025 and is being funded by the Defense Logistics Agency (DLA), which serves as the medical supply chain for the Department of Defense. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a range of...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $4,373.96 firm-fixed-price contract covers the supply of epinephrine auto-injectors to support the recurring medical needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,154 firm fixed-price contract is for the delivery of epinephrine auto-injectors, with a period of performance through May 23, 2025. DMS Pharmaceutical Group has a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...